GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (FRA:4OR1) » Definitions » 5-Year EBITDA Growth Rate

Organovo Holdings (FRA:4OR1) 5-Year EBITDA Growth Rate : 18.50% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings 5-Year EBITDA Growth Rate?

Organovo Holdings's EBITDA per Share for the three months ended in Dec. 2024 was €-0.18.

During the past 3 years, the average EBITDA Per Share Growth Rate was 12.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 18.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Organovo Holdings was 34.10% per year. The lowest was -508.50% per year. And the median was 16.15% per year.


Competitive Comparison of Organovo Holdings's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Organovo Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organovo Holdings's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Organovo Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Organovo Holdings's 5-Year EBITDA Growth Rate falls into.



Organovo Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Organovo Holdings  (FRA:4OR1) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Organovo Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Organovo Holdings Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Organovo Holdings Headlines

No Headlines